Summary
Results concerning the metabolism and pharmacokinetics of Sulpiride in rats have been previously reported.
The present study describes the separation, quantification and determination of the chemical structure of the sulpiride metabolites found in the urine and plasma of rats, dogs and humans. The metabolites were separated by means of multicolumn HPLC and their structure then determined by mass spectrometry, IR and UV spectroscopy. Furthermore, the chemical structure of the six isolated metabolites as well as unchanged product obtained by biological pathways was confirmed by comparison with that of the synthesized reference products.
The metabolites obtained from rat and dog were: 5-aminosulfonyl-N-[(1-ethyl-2-pyrrohdinyl)methyl]-2-hydroxybenzamide (in rat only), 5-amtaosulfonyl-N-[(2-pyrroBdlnyl)methyl]-2-hydroxybenzamide,5-anunosulfonyl-N-[(l-ethyl-5-oxo-2-pyrroUdin zamide, 5-aminosulfonyl-2-methoxybenzamide, 5-aminosulfonyl-N-[(l-ethyl-5-oxo-2-pyrrolidinyl)methyl)-2-methoxybenzamide,5-aminosulfonyl-N-[(2-pyrrolidinyl)methyl]-2-methoxybenzamide.
In the rat, metabolites represented 56% of the administered drug of which 38% were conjugates; in the dog, they represented 15% of which 4% were conjugates. None of these metabolites was found in human urine; the pharmacological properties of sulpiride could therefore be attributed to the unchanged product.
Similar content being viewed by others
References
Justin-Besancon L., Thominet M., Laville C. and Margarit J. (1967): Constitution chimique et propriétés biologiques du sulpiride. C.R. Acad. Sc. Paris,265, série D, 1253–1254.
Laville C. and Margarit J. (1969): Sur les effets neurologjques centraux du sulpiride. Pathol. Biol.,7, 71–75.
Borenstein P., Champion C, Cujo P., Gekiere F., Olivenstein C. and Kramarz P. (1969): Un psychotrope original: le sulpiride. Sem. Hôp.,45, 1301–1314.
Robert P. (1969): Nouveaux développements dans le domaine des neuroleptiques. Sem. Ther.,45, 291–293.
Benakis A., Pongis M.-A., Sugnaux F.R. and Glasson B. (1976): Localization, distribution, elimination and metabolism of14C-Sulpiride in rats. Europ. J. Drug Metabolism and Pharmacokinetics,1, 51–62.
Noël J.P., Benakis A., Herbert M., Pichat L. et Thominet M. (1972): Synthèse du N-[(éthyl-l pyrrohdinyl-2) méSthyl] methoxy-2 sulfamoyl-5 benzamide (Sulpiride) marqué au14C. J. Lab. Comp.,8, 665–676.
Bradshaw L.R.A. (1969): The detection of sulphonamido groups. J. Chromatog.,44, 422–424.
Sugnaux F.R. (1977): Chromatographic liquide haute pression (HPLC) et métabolisme des médicaments. Application à la séparation des métabolites du sulpiride dans les milieux biologiques. Doctoral Thesis No. 1806, Fac. Sciences, Genève, Switzerland.
Imondi A.R., Alam A.S., Brennan J.J. and Hagerman L.M. (1978): Metabolism of Sulpiride in Man and Rhesus Monkeys. Arch. int. Pharmacodyn.,232, 79–91.
Williams R.T. (1967): Comparative patterns of drug metabolism. Federation Proceedings,26, 1029–1039.
Cowan D.A., Huizing G. and Beckett A.H. (1976): Identification of Four New Metabolic Products of Metoclopramide using Mass Spectrometry. Xenobiotica,6, 605–616.
Teng L., Bruce R.B. and Dunning L.K. (1977): Metoclopramide Metabolism and Determination by High-Pressure Liquid Chromatography. J. Pharm. Sci.,66, 1615–1618.
Brodasky T.F., Lewis C. and Eble T.E. (1977): Distribution and metabolism of antibiotics in the whole animal. I. Clindamycin in the rat. Europ. J. Drug Metabolism and Pharmacokinetics,3, 149–156.
Bickel M.H. (1971): N-Oxide Formation and Related Reactions in Drug Metabolism. In “Biological Oxidation of nitrogen in Organic molecules” edited by Bridges J.W., Gorrod J.W. and Parke D.V., Taylor and Francis Ltd, London, 1–7.
Beckett A.H., Gorrod J.W. and Jenner P. (1971): The analysis of nicotine-1′-N-oxide in urine, in the presence of nicotine and cotinine, and its application to the study ofin vivo nicotine metabolism in man. J. Pharm. Pharmac,23, Suppl, 55S-61S.
Hucker H.B., Stauffer S.C. and Rhodes R.E. (1972): Metabolism of a Pharmacologically Active Pyrrolidine Derivative (Prolintane) by Lactam Formation. Experientia,28, 430–431.
Hammar C.G., Hammer W., Holmstedt B., Karlen B., Sjoqvist F. and Vessman J. (1969): Metabolism of tremorine. Identification of 1,4-bis (2-oxopyrrolidino)-2-butyne (symmetric dioxotremorine). Biochem. Pharmacol.,18, 1549–1551.
Paxke D.V. (1968): Metabolic transformations catalysed by hepatic microsomal enzymes. In “The Biochemistry of Foreign Compounds”, Pergamon Press, Oxford, 34–55.
Benakis A. (1978): Metabolism and pharmacokinetics of a substituted benzamide, sulpiride, in animals: specific localization and neuroendocrinological aspect. In “Neuro-psychopharmacology”, Proceedings of the Tenth Congress of the C.I.N.P. Québec, July 4–9, 1976. Edited by Deniker P., Radouco-Thomas C. and Villeneuve A., Pergamon Press, Oxford, 849–863.
Sugnaux F.R. (1978): Separation and determination of sulpiride conjugates in the rat. In “Conjugation Reactions in Drug Biotransformation”, Proceedings of the IUPHAR satellite symposium No 7, Turku, Finland, July 23–26, 1978. Edited by Aitio A., Elsevier/North-Holland, Amsterdam (in press).
Colucci D.F. and Buyske D.A. (1965): The biotransformation of a sulfonamide to a mercaptan and to mercapturic acid and glucuronide conjugates. Biochem. Pharmac,14, 457–466.
Rosenblum C, Trenner N.R. and Wolf D.E. (1971): The non-metabolite residue. A limitation to the tracer method. J. Lab. Comp.,7, 225–232.
Author information
Authors and Affiliations
Additional information
A first account of this work was presented at the Seventh International Congress of Pharmacology, IUPHAR, Paris, France, July 16–21,1978.
Rights and permissions
About this article
Cite this article
Sugnaux, F.R., Benakis, A. Metabolism of sulpiride: Determination of the chemical structure of its metabolites in rat, dog and man. European Journal of Drug Metabolism and Pharmacokinetics 3, 235–248 (1978). https://doi.org/10.1007/BF03189389
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189389